Step | Measure | B | P | Odds Ratio | % Corr. Class | R2 |
---|---|---|---|---|---|---|
1 | MRI hippocampus | −2.306 | .000 | .100 | NC: 83.3 | .601 |
AD: 81.6 | ||||||
All: 82.5 | ||||||
2 | MRI hippocampus | −2.029 | .000 | .132 | NC: 88.1 | .733 |
t-τ:Aβ42 | 2.141 | .001 | 8.509 | AD: 81.6 | ||
All: 85.0 | ||||||
3 | MRI hippocampus | −1.861 | .002 | .155 | NC: 90.5 | .778 |
MRI retrosplenial | −1.239 | .028 | .290 | AD: 86.8 | ||
t-τ:Aβ42 | 2.411 | .002 | 11.140 | All: 88.8 | ||
NC vs MCI | ||||||
1 | MR hippocampus | −1.360 | .000 | .257 | NC: 54.8 | .312 |
MCI: 80.8 | ||||||
All: 71.3 | ||||||
2 | MR hippocampus | −1.124 | .000 | .325 | NC: 64.3 | .399 |
t-τ:Aβ42 | 1.422 | .006 | 4.146 | MCI: 87.7 | ||
All: 79.1 |
a The variables explaining unique variance within each method, as listed in Table 2, were included in the set of predictor variables, i.e. for MR: hippocampal volume, retrosplenial, and entorhinal thickness; for PET: entorhinal, retrosplenial, and lateral orbitofrontal metabolism; and for CSF: the ratio of T-tau to Abeta 42. R2 is Nagelkerke R2.